Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07830667) titled 'A Phase 1/2 Study of CBX-12 in Children, Adolescents, or Young Adults With Solid Tumors That Have Come Back After Treatment or Are Difficult to Treat' on Sept. 15.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Children's Oncology Group
Condition:
Recurrent Childhood Ewing Sarcoma
Recurrent Childhood Malignant Solid Neoplasm
Recurrent Childhood Rhabdomyosarcoma
Recurrent Ewing Sarcoma
Recurrent Extracranial Malignant Solid Neoplasm
Recurrent Rhabdomyosarcoma
Refractory Childhood Ewing ...